B+
Bull case
30%
Probability
Target price
$48.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
AXGN
AxogenCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The cleanest post-earnings read is that Axogen paired strong top-line growth with better gross margin and enough confidence to raise full-year revenue guidance, while payer coverage and CMS coding tailwinds give the commercial story more substance than a generic medtech growth narrative [#8-K-2026-04-28] [#10-Q-2026-04-28].
Posture
Mixed
Lead driver
Sentiment
What changed
1 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Execution risk remains high around translating payer wins and improved CMS reimbursement into durable case-volume growth rather than a one-quarter sentiment boost.
Momentum
74
Value
42
Sentiment
61
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $42.00 · Bull $48.00 · Bear $33.00Analysis 2026-04-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $53.90
Why
Momentum74 · Δ7d -14.6
Value42 · Δ7d -0.0
Sentiment61 · Δ7d +4.6
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-09-09.
- • Sentiment remains the lead driver in the composite, 7D delta +4.6.
Contradictions & invalidation
- • Execution risk remains high around translating payer wins and improved CMS reimbursement into durable case-volume growth rather than a one-quarter sentiment boost.
- • GAAP profitability is still weak: Q1 net loss was $19.6M, with sales and marketing, R&D, and G&A all up year over year.
- • The caution is that GAAP net loss widened to $19.6M, operating expenses remained elevated, and part of the quarter’s improvement depends on add-backs and one-time debt-extinguishment mechanics; consensus-surprise data and delayed post-print estimate revisions were not confirmed from primary sources checked, so the follow-up remains a monitoring view rather than a strong upgrade.
Catalyst clock
2026-05-31
Q1 print plus raised 2026 outlook reset the near-term setup
Lead driver: Sentiment · See AI snapshot
Momentum
74
9% active weight
Current posture
7d trendSoftening
Δ7d
-14.6
Δ21d
-11.0
Value
42
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-5.3
Sentiment
61
62% active weight
Current posture
7d trendImproving
Δ7d
+4.6
Δ21d
+3.6
Why this grade
Composite grade C. Momentum 74.0 / Value 41.9 / Sentiment 61.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-29. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$42.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$33.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.64B
Beta
1.00
Shares Out
53.76M
P/E (TTM) · Derived
-144.1
P/S (TTM)
6.82
P/FCF (TTM)
711.09
Rev YoY
+23.1%
EPS YoY
-334.7%
Gross Margin
+74.6%
Op Margin
-5.1%
Net Debt
$22.1M
Current Ratio
6.60
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data